trial
as of 2026-07-01Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder
NCTId NCT00501618
at a glance
Phase 4 · Completed
Enrollment 20 (actual)
Sponsored by Manhattan Psychiatric Center
Primary completion 2009-03
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
20 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2006-11
Primary completion
2009-03
Eligibility
ALL · 18 Years · 59 Years
Interventions & indications
Sponsors
Manhattan Psychiatric CenterLead Sponsor
Azur Pharma, IncCollaborator
Investigators
2
Jean-Pierre Lindenmayer, MDPrincipal Investigator
Saurabh Kaushik, MDStudy Chair
Sites
2 total
New York, United StatesNew York, United States
Facts & assertions
4 sourced
Enrollment
20
Phase
PHASE4
Primary Completion Date
2009-03
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
collaborator
company
indication
investigator
person